Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the ...

We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

NPPA fixes retail price of 42 formulations, revise prices based on review orders: Our Bureau, New Delhi Tuesday, February 11, 2025, 13:30 Hrs [IST] The National Pharmaceutical Pri ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

This study aimed to evaluate the real-world effectiveness and safety of tenofovir amibufenamide (TMF) in a cohort of patients with chronic hepatitis B (CHB). In this multicenter, prospective ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza, has ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Lupin: Drug manufacturer Lupin Ltd. received tentative approval from the U.S. FDA for its generic version of a combination ...